PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway

por Lv, Shidong, Wang, Wei, Wang, Hongyi, Zhu, Yongtong, Lei, Chengyong
Publicado 2019

HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways

por Lv, Daojun, Wu, Huayan, Xing, Rongwei, Shu, Fangpeng, Lei, Bin, Lei, Chengyong, Zhou, Xumin, Wan, Bo, Yang, Yu, Zhong, Liren, Mao, Xiangming, Zou, Yaguang
Publicado 2017

Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer

por Wang, Wei, Zhang, Xuecong, Zhu, Xiaohui, Cui, Wenzhi, Ye, Danli, Tong, Guihui, Huang, Dingpeng, Zhou, Juan, Lai, Xuwen, Yan, Guangning, Li, Xia, Fan, Jianbing, Zhu, Hongwu, Lei, Chengyong
Publicado 2022

Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4

por Lv, Shidong, Ji, Liyan, Chen, Bin, Liu, Shuqiang, Lei, Chengyong, Liu, Xi, Qi, Xiaoxiao, Wang, Ying, Lai-Han Leung, Elaine, Wang, Hongyi, Zhang, Lin, Yu, Xiaoming, Liu, Zhongqiu, Wei, Qiang, Lu, Linlin
Publicado 2017